CME Group Inc. (CME) — Fair Value Analysis

Base-case fair value (P50): $332.88 · Current price: $305.10 · Verdict: Fairly Valued

The Verdict on CME

Based on comprehensive Monte Carlo simulations, CME Group (CME) is currently assessed as Fairly Valued. Our analysis indicates a median fair value (P50) of $332.88, suggesting a potential +9.1% upside from the current market price of $305.10. While this implies some potential for appreciation, it aligns CME closely with its intrinsic valuation when considering a vast array of forward-looking financial scenarios. The Monte Carlo approach, by simulating thousands of possibilities, provides a robust understanding of CME's likely valuation range, anchoring the current assessment that it is neither significantly overvalued nor undervalued at $305.10.

How CME stacks up against Financial Services

Within the Financial Services sector, CME Group maintains an "average" quality tier, reflecting its operational and financial health relative to peers. This average standing, combined with our fair value assessment, suggests that CME is performing broadly in line with expectations for a company of its caliber in the sector. The median fair value of $332.88 incorporates this operational context, indicating that the market's current price of $305.10 adequately reflects CME's fundamental strengths and challenges without presenting a compelling discount or premium. Investors should view the +9.1% as potential within this context, rather than a deep value opportunity.

What this means for investors

For investors, the "Fairly Valued" verdict signals that CME's current share price of $305.10 largely reflects its underlying fundamentals, with our Monte Carlo analysis showing a median fair value of $332.88. While there's a +9.1% potential according to our P50 estimate, this valuation implies that significant mispricing is unlikely based on thousands of simulated outcomes. The FairCurve platform empowers investors to move beyond single-point estimates. To fully understand CME's valuation, including the complete probability distribution of potential bear and bull cases and to track its fair value as new financial data emerges, sign up for a free FairCurve account today.